US EditionPublished • loading... • Updated
Theravance Biopharma (NASDAQ:TBPH) Releases Earnings Results, Beats Expectations By $0.71 EPS
Summary by watchlistnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Theravance Biopharma (NASDAQ:TBPH) Releases Earnings Results, Beats Expectations By $0.71 EPS
Theravance Biopharma (NASDAQ:TBPH – Get Free Report) posted its quarterly earnings data on Thursday. The biopharmaceutical company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.44 by $0.71, FiscalAI reports. The company had revenue of $45.89 million for the quarter, compared to the consensus estimate of $43.09 million. Theravance […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
